"The American Society of Clinical Oncology (ASCO) meeting emphasized the role of tumor biology in treatment decisions. New studies show targeted therapies based on molecular alterations significantly improve survival rates. Precision oncology is shifting focus from organ-specific treatment to biology-based approaches."